DCF vs. EBITDA multiple: why business valuation needs more than one perspective

Begin with the valuation question

The same company can be analysed for a shareholder sale, a management buyout, an acquisition, an internal transfer or strategic planning. Before selecting a model, define the valuation date, the interest being valued, the basis of value, the available information and the intended use. Those choices determine which cash flows, market participants and adjustments are relevant.

International Valuation Standards distinguish the market, income and cost approaches and require methods to be appropriate for the circumstances. IFRS 13 makes a similar point for fair-value measurement: use techniques suited to the circumstances and supported by sufficient data. That is why the answer should not start with a preferred spreadsheet template.

What the income approach and DCF actually test

Under the income approach, future amounts are converted into a current value. A DCF usually models an explicit forecast period and a value for cash flows beyond it. For an enterprise-value DCF, the central economic measure is free cash flow available to providers of capital—not accounting profit in isolation.

Revenue and margin assumptions must connect to working-capital needs, capital expenditure, tax and operating cash conversion. A business can report rising EBITDA while consuming cash through inventory, receivables or investment. The discount rate must be consistent with the risk and currency of the cash flows; terminal value in the model without making the underlying risk disappear is not analysis.

The terminal value deserves particular attention because it represents the period after the explicit forecast. Whether it is estimated through a continuing-growth model or an exit multiple, the assumptions must be consistent with mature economics, reinvestment and the valuation date. Sensitivities should reveal which conclusions change when growth, margin, cash conversion, investment or risk changes.

What an EBITDA multiple can—and cannot—show

The market approach compares the subject with businesses or interests for which price information is available. A trading multiple comes from quoted-company market data. A transaction multiple comes from completed or announced deals, subject to the quality and meaning of the disclosed information. The two are not interchangeable: transaction terms may reflect control, synergies, timing and deal-specific conditions that a quoted price does not.

Before applying any multiple, establish the denominator. The analysis should reconcile reported results to normalized EBITDA and document owner items, related-party terms, one-offs and accounting classifications. A multiple drawn from one EBITDA definition cannot safely be applied to another without adjustment.

Comparable does not mean identical. Business mix, geography, scale, growth, margins, customer concentration, recurring revenue, capital intensity, governance and liquidity can all affect whether evidence deserves weight. If those differences cannot be understood, the apparent precision of a market multiple is misleading.

A practical comparison

Why the two indications may diverge

A DCF may imply more value than market evidence because management expects faster growth, better margins or lower reinvestment than the comparables currently demonstrate. The reverse may occur when market prices embed strategic expectations, scarcity or a different risk environment. The gap is information: it identifies assumptions that require proof.

Reconciliation should ask whether the forecast is achievable, whether the comparable group is genuinely relevant, whether both methods use the same valuation date and capital structure logic, and whether enterprise value has been distinguished from equity value. Net debt, debt-like items, surplus cash and any agreed working-capital adjustment sit between an enterprise-value indication and what shareholders may receive.

• →Trace the gap to growth, margin, reinvestment, cash conversion or risk.
• →Separate standalone value from buyer-specific synergies.
• →Check whether transaction evidence includes control or unusual terms.
• →Align historical, current and forward EBITDA periods before comparison.
• →Explain why each method receives its weight; do not average by default.

Value is not the same as transaction price

A valuation is an analysis under a defined basis and date. An actual price is negotiated between identified parties and can reflect competition, financing, synergies, timetable, warranties, earn-outs, retained stakes and risk allocation. A disciplined sell-side process or buy-side decision therefore keeps valuation, price and contract economics connected but distinct.

The most useful conclusion is often a range linked to assumptions and decision points. It tells the owner or investment committee what must be true for a value case to hold, which evidence is still missing and where the transaction structure transfers rather than eliminates risk.

A review sequence before relying on the result

1. 01

   Define the assignment

   Record purpose, date, basis of value, ownership interest and intended users.

2. 02

   Reconcile the history

   Tie revenue, EBITDA, debt and working capital to the underlying records.

3. 03

   Normalize consistently

   Document each adjustment and treat positive and negative exceptional items symmetrically.

4. 04

   Build the cash logic

   Connect operating drivers to tax, investment and working-capital cash flows.

5. 05

   Select market evidence

   Explain inclusion, exclusion, period and adjustments for every comparable.

6. 06

   Reconcile the indications

   Turn differences into explicit commercial and financial questions.